Patents by Inventor Greg del Val

Greg del Val has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
    Patent number: 11926663
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: March 12, 2024
    Assignee: AB2 BIO SA
    Inventors: Greg Del Val, Eduardo Schiffrin
  • IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
    Patent number: 11820817
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: November 21, 2023
    Assignee: AB2 Bio SA
    Inventors: Greg Del Val, Eduardo Schiffrin
  • IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases
    Publication number: 20230250164
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Application
    Filed: November 14, 2022
    Publication date: August 10, 2023
    Inventors: Andrea Pfeifer, Greg Del Val
  • IL-18 binding protein (IL-18BP) in inflammatory diseases
    Patent number: 11530263
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: December 20, 2022
    Assignee: AB2 Bio SA
    Inventors: Andrea Pfeifer, Greg Del Val
  • IL-18 BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES
    Publication number: 20210188968
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Application
    Filed: March 8, 2021
    Publication date: June 24, 2021
    Inventors: Greg DEL VAL, Eduardo SCHIFFRIN
  • IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
    Patent number: 10882905
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: January 5, 2021
    Assignee: AB2 BIO SA
    Inventors: Greg Del Val, Eduardo Schiffrin
  • IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES
    Publication number: 20200392222
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Application
    Filed: May 26, 2020
    Publication date: December 17, 2020
    Inventors: Andrea PFEIFER, Greg DEL VAL
  • IL-18 binding protein (IL-18BP) in inflammatory diseases
    Patent number: 10858426
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: December 8, 2020
    Assignee: AB2 BIO SA
    Inventors: Andrea Pfeifer, Greg Del Val
  • IL-18 BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES
    Publication number: 20200377586
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Application
    Filed: May 26, 2020
    Publication date: December 3, 2020
    Applicant: AB2 BIO SA
    Inventors: Greg DEL VAL, Eduardo SCHIFFRIN
  • IL-18 BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES
    Publication number: 20180127494
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Application
    Filed: March 3, 2016
    Publication date: May 10, 2018
    Applicant: AB2 BIO SA
    Inventors: Greg DEL VAL, Eduardo SCHIFFRIN
  • IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES
    Publication number: 20160215048
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Application
    Filed: September 5, 2014
    Publication date: July 28, 2016
    Inventors: Andrea PFEIFER, Greg DEL VAL
  • Methods for the production of multimeric proteins and related compositions
    Publication number: 20090197337
    Abstract: Improved methods for the production of multimeric-protein-complexes, such as redox proteins and immunoglobins, in association with oil bodies are described. The redox protein is enzymatically active when prepared in association with the oil bodies. Also provided are related nucleic acids, proteins, cells, plants, and compositions.
    Type: Application
    Filed: December 19, 2001
    Publication date: August 6, 2009
    Inventors: Gijs Van Rooijen, Harm Deckers, Steven Briggs, Bipin Kumar Dalmia, Greg Del Val, Steve Zaplachinski, Maurice Moloney, Peter Bernard Heifetz
  • Nucleic acids and proteins with thioredoxin reductase activity
    Publication number: 20060149482
    Abstract: The present invention relates to the use of a variety of methods for generating functional thioredoxin reductase variants in which at least one physical, chemical or biological property of the variant is altered in a specific and desired manner when compared to the wild-type protein.
    Type: Application
    Filed: December 22, 2005
    Publication date: July 6, 2006
    Inventors: Bipin Dalmia, Steven Briggs, Greg del Val, John Desjarlais, Peter Heifetz, Peter Luginbuhl, Umesh Muchhal
  • Nucleic acids and proteins with thioredoxin reductase activity
    Patent number: 7071307
    Abstract: The present invention relates to the use of a variety of methods for generating functional thioredoxin reductase variants in which at least one physical, chemical or biological property of the variant is altered in a specific and desired manner when compared to the wild-type protein.
    Type: Grant
    Filed: May 6, 2002
    Date of Patent: July 4, 2006
    Assignees: Syngenta Participations AG, Xencor, Inc.
    Inventors: Bipin K. Dalmia, Steven P. Briggs, Greg del Val, John R. Desjarlais, Peter Heifetz, Peter Luginbuhl, Umesh Muchhal
  • Mucolytic and anti-elastase compounds and methods of use thereof
    Publication number: 20050260140
    Abstract: Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. Also disclosed are compositions and methods for inhibiting elastase in a patient. The compositions contains a compound containing a dithiol active-site in reduced state and optionally further contains a reducing system.
    Type: Application
    Filed: March 24, 2005
    Publication date: November 24, 2005
    Applicants: National Jewish Medical and Research Center, The United States Government as Represented by the Secretary of the Navy
    Inventors: Carl White, Greg Del Val, Rees Lee
  • Nucleic acids and proteins with thioredoxin reductase activity
    Publication number: 20030211511
    Abstract: The present invention relates to the use of a variety of methods for generating functional thioredoxin reductase variants in which at least one physical, chemical or biological property of the variant is altered in a specific and desired manner when compared to the wild-type protein.
    Type: Application
    Filed: November 6, 2002
    Publication date: November 13, 2003
    Inventors: Steven P. Briggs, Bipin K. Dalmia, Greg del Val, John R. Desjarlais, Peter Heifetz, Peter Luginbuhl, Umesh Muchhal
  • Methods for the production of multimeric protein complexes, and related compositions
    Publication number: 20030167524
    Abstract: Improved methods for the production of multimeric-protein-complexes, such as redox proteins and immunoglobulins, in association with oil bodies are described. The redox protein is enzymatically active when prepared in association with the oil bodies. Also provided are related nucleic acids, proteins, cells, plants, and compositions.
    Type: Application
    Filed: December 19, 2001
    Publication date: September 4, 2003
    Inventors: Gijs Van Rooijen, Steven Zaplachinski, Peter-Bernard Heifetz, Steven Briggs, Bipin Kumar Dalmia, Greg Del Val
  • Nucleic acids and proteins with thioredoxin reductase activity
    Publication number: 20030100743
    Abstract: The present invention relates to the use of a variety of methods for generating functional thioredoxin reductase variants in which at least one physical, chemical or biological property of the variant is altered in a specific and desired manner when compared to the wild-type protein.
    Type: Application
    Filed: May 6, 2002
    Publication date: May 29, 2003
    Inventors: Bipin K. Dalmia, Steven P. Briggs, Greg del Val, John R. Desjarlais, Peter Heifetz, Peter Luginbuhl, Umesh Muchhal